Furthermore, decreased expression of CCL5 and elevated viral load of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in nasopharyngeal samples were associated with poor outcomes of coronavirus disease 2019 (COVID-19) [14]. This evidence concerns the gene CCL5 and COVID-19.